augustinetx.com
Contact us
About company
Augustine Therapeutics company is a two drug discovery programs to identify new selective HDAC6 inhibitors and GABABR1a agonists for the treatment of neurological diseases such as Charcot Marie Tooth disease. These new compounds have the potential to protect from nerve degeneration and promote peripheral myelin repair.
BE
Unknown
Unknown
Not verified company
